Skip to main content
Nanotheranostics logoLink to Nanotheranostics
. 2023 Jan 1;7(1):90. doi: 10.7150/ntno.75006

Engineering Extracellular Vesicles to Target Pancreatic Tissue In Vivo: Erratum

Hiroaki Komuro 1,2,6,*, Yuki Kawai-Harada 2,6,*, Shakhlo Aminova 2,3, Nathaniel Pascual 2,4, Anshu Malik 2,6, Christopher H Contag 2,5,6, Masako Harada 2,6,
PMCID: PMC9760369  PMID: 36593798

In the original paper on p.380 and p.381, Material and Methods “Cell Culture and Treatment” section, there is an error in the construct used to label EVs for fluorescence. Our original paper incorrectly states that we used pcDNA-mCherry-C1C2 when it should have been pcS-mCherry-C1C2. The main differences between these two constructs are the backbone size, as pcS-mCherry-C1C2 is smaller by approximately 2kbp, without any changes in the protein-coding region.

In addition, on p.379 and p.380, Material and Methods “EV-peptide display plasmid construction” section, the pcDNA-mCherry-C1C2 was subjected to remove unnecessary sequences through the single-piece SLiCE reaction of the PCR fragments using the same method to pcS-p88-C1C2 or pcS-pep1-C1C2. These corrections do not change the main conclusions of this article.


Articles from Nanotheranostics are provided here courtesy of Ivyspring International Publisher

RESOURCES